4//SEC Filing
Tamboli Ajim 4
Accession 0000899243-22-008707
CIK 0001826457other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 6:47 PM ET
Size
5.4 KB
Accession
0000899243-22-008707
Insider Transaction Report
Form 4
Tamboli Ajim
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-03-01+111,700→ 111,700 totalExercise: $13.41Exp: 2032-02-29→ Common Stock (111,700 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on January 1, 2023, with the remainder vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Monte Rosa Therapeutics, Inc.
CIK 0001826457
Entity typeother
Related Parties
1- filerCIK 0001855684
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 6:47 PM ET
- Size
- 5.4 KB